title: Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
authors.affiliation: Department of Clinical Pharmacology and Cardiology, University Hospital, Groningen, The Netherlands.
authors.forename: Peter Paul
authors.initials: PP
authors.lastname: van Geel
authors.forename: Hendrik
authors.initials: H
authors.lastname: Buikema
authors.forename: Jean-Lucien
authors.initials: JL
authors.lastname: Rouleau
authors.forename: Wiek H
authors.initials: WH
authors.lastname: van Gilst
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D017558:Elective Surgical Procedures; D005260:Female; D005838:Genotype; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000097:blood* / Q000235:genetics*; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril